Pharmaceutical Review Designations – Trends and Industry Insights
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
This report investigates review designations in the pharmaceutical industry from the standpoint of drug development. It provides an in- depth review of the history and available designations alongside high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern teh impact these designations have had on the market and on the drug products themselves.
Scope
This 48-page report gives important, expert insight you won’t find in any other source. 23 figures throughout the report illustrate major points, trends and impacts review designations have had upon the Pharmaceutical industry. This report is required reading for:
Investors that want to understand the impact key review designations like Orphan Drug Designations could have on companies.
Professional Services that are interested in understanding the impact review designations have had on the Biopharmaceutical industry
Large pharma companies interested in lifecycle management of their portfolio and want to see how they can extend or expand their portfolios’ reach
Small and medium pharma who may want to secure review designations and want to see how it could impact their portfolio
Reasons to Buy
Insights on how review designations impacted drug development
Insights on what Review Designations are and their specific trends within the pharmaceutical industry.
Sales insights covering various drugs and companies, providing illumination into how review designations can influence potential sales on a current and historical analysis
Merck & Co,Novartis AG
Johnson & Johnson
Abbvie
F.Hoffman-La Roche Ltd
Bristol-Myers Squibb Co
Astrazeneca Plc
Takeda Pharmaceutical
GlaxoSmithKline Plc
GSK
Amgen
Novartia AG
Sanofi
Ono Pharmaceutical
Beigene
Yangtze River Pharmaceutical group
Zai Lab
Sino Biopharmaceutical
Innovent Biologics
Jiangsu Hengrul Medicine
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Pharmaceuticals reports